Skip to main content
Adverse impact of regional lymph node involvement in osteosarcoma.
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.
Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas.
Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma.
International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
Telomerase expression in primary neuroblastomas.
Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results.